Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SPY
6. MMED
7. CRDO
8. AAPL
9. MDT
10. GFS

Go back to Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA)
(NASDAQ: NTLA) Delayed: 12.67 -0.01 (0.08%)
Previous Close $12.68    52 Week High $30.40 
Open $12.67    52 Week Low $11.86 
Day High $13.13    P/E N/A 
Day Low $12.65    EPS $0.00 
Volume 563,640